Prenatal Testing Market Size To Be Worth USD 8.08 Billion by 2027 | Emergen Research

The growing awareness of the benefits of advanced testing procedures and rising incidences of miscarriage is driving the demand for the prenatal testing market.

Vancouver, British Columbia, Dec. 07, 2020 (GLOBE NEWSWIRE) -- The Global Prenatal Testing Market is forecast to be worth USD 8.08 Billion by 2027, according to the current analysis by Emergen Research. The rapid growth of the Prenatal Testing Market can be attributed to the growing awareness of the benefits of advanced testing procedures. Moreover, the increasing incidences of miscarriage are anticipated to further drive market growth over the forecasted period. Furthermore, the rising government initiatives to encourage prenatal testing as well as several favorable checkup schemes for below poverty communities in developing and underdeveloped nations are also expected to boost the market growth of the prenatal testing market over the forecast timeframe.

However, in developing and underdeveloped countries, the lack of advanced healthcare services is expected to hinder market development over the forecast timeline.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@

Key Highlights From The Report

  • In September 2020, Grail Inc. was acquired by Illumina, Inc. With this acquisition, Illumina planned to introduce the standardized and widely available blood-based screening, which allows early diagnosis of cancer while treatment can be more accurate and less expensive.
  • Over the forecast timeframe, the Trisomy segment is expected to dominate the market with a CAGR of 13.2%. It can primarily be attributed to forces, including increased maternal age and a growing number of chromosome abnormalities.
  • Due to the propensity for Prenatal Testing for microdeletion and microduplication syndromes in patients, the Micro-deletions Symptoms segment is expected to grow significantly.
  • As non-invasive prenatal testing and substantial technological advancements in the field of prenatal testing are being rapidly integrated, the involvement of professionals and a higher reimbursement scenario are happening; the hospital segment is expected to witness considerable growth over the forecast timeframe.
  • During the forecast period, the Asia Pacific market is projected to see significant growth. Elevated development can be due to factors like the growing consumption of unhealthy diets.
  • Key participants include Quest Diagnostics, GeneDx, Inc., Natera, Inc., Illumina, Inc., Ravgen Inc., Prenatal Paternities Inc., Ariosa Diagnostics, Inc., Eurofins NTD Inc., Counsyl, Inc., and LabCorp.

ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@

Emergen Research has segmented the Global Prenatal Testing Market on the basis of method, test type application, end-use, and region:

  • Method Outlook (Revenue, USD Billion; 2017-2027)
    • Blood or Saliva
    • Urine
    • Ultrasound
    • Amniocentesis
    • Chorionic villus sampling
    • Percutaneous umbilical blood sampling
  • Test Type Outlook (Revenue, USD Billion; 2017-2027)
    • Invasive
    • Non-Invasive
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Microdeletions Symptoms
    • Trisomy
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2017-2027)
    • Specialty Clinics
    • Hospitals
    • Diagnostic Centers

To identify the key trends in the industry and read full summary click on the link:

  • Regional Outlook (Revenue, USD Billion; 2017-2027)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. U.A.E.
      3. Rest of MEA

Take a Look at our Related Reports:

In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027

Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027

Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@

Contact Data